Have a personal or library account? Click to login
Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-Val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam Cover

Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-Val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam

By: LD Thuan,  ND Kha,  NT Minh and  LHA Thuy  
Open Access
|Aug 2019

References

  1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964; 1(7335): 702-703.14107961
  2. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970; 228(5276): 1056-1058.432065710.1038/2281056a0
  3. Young LS, Murray PG. Epstein-Barr virus and on-cogenesis: From latent genes to tumours. Oncogene. 2003; 22(33): 5108-5121.10.1038/sj.onc.120655612910248
  4. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004; 10(3): 803-821.10.1158/1078-0432.CCR-0670-314871955
  5. Saha A, Robertson ES. Epstein-Barr virus-associated B-cell lymphomas: Pathogenesis and clinical outcomes. Clin Cancer Res. 2011; 17(10): 3056-3063.2137221610.1158/1078-0432.CCR-10-2578
  6. Tsurumi T, Fujita M, Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol. 2005; 15(1): 3-15.10.1002/rmv.44115386591
  7. Chao M, Wang HN, Lu YJ, Chang YS, Yu JS. The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal. Oncol Rep. 2015; 33(2): 958-966.2543429210.3892/or.2014.3625
  8. Kang MS, Kieff E. Epstein-Barr virus latent genes. Exp Mol Med. 2015; 47(2): el31.
  9. Sun L, Zhao Z, Liu S, Liu X, Sun Z, Luo B. Sequence variation analysis of Epstein-Barr virus nuclear antigen 1 gene in the virus associated lymphomas of Northern China. PLoS One. 2015; 10(10): e0140529.10.1371/journal.pone.014052926460969
  10. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol. 1991; 65(3): 1466-1478.1847464
  11. Goldsmith K, Bendell L, Frappier L. Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J Virol. 1993; 67(6): 3418-3426.8388506
  12. Frappier L, O'Donnell M. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J Biol Chem. 1991; 266(12): 7819-7826.1850421
  13. Do NV, Ingemar E, Phi PT, Jenny A, Chinh TT, Zeng Y, et al. Amajor EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res. 2008; 132(1-2): 15-24.10.1016/j.virusres.2007.10.020
  14. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, et al. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene. 1996; 13(1): 177-181.8700544
  15. Gutiérrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, et al. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol. 1997; 78 (Pt 7): 1663-1670.10.1099/0022-1317-78-7-16639225043
  16. Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, et al. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of naso-pharyngeal carcinoma. Cancer Lett. 2004; 211(1): 11-18.10.1016/j.canlet.2004.01.035
  17. Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res Perspect. 2016; 7(6): 360-372.10.1016/j.phrp.2016.11.00228053841
  18. Lao TD, Phuong TK, LE TAH. Study of Epstein-Barr virus nuclear antigen (EBNA-1) variations: V-val type preferentially exists in biopsies of nasopharyngeal carcinoma from Vietnamese patients. Iran J Ped Hematol Oncol. 2018; 8(2): 75-86.
  19. Wang Y, Liu X, Xing X, Cui Y, Zhao C, Luo B. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res. 2010; 147(2): 258-264.1994191510.1016/j.virusres.2009.11.010
  20. Chen YY, Chang KL, Chen WG, Shibata D, Hayashi K, Weiss LM. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Lab Invest. 1998; 78(7): 877-882.9690565
  21. Sandvej K, Zhou XG, Hamilton-Dutoit S. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: Evidence for geographical polymorphism but not for tumour-specific subtype restriction. JPathol.2000; 191(2): 127-131.10.1002/(SICI)1096-9896(200006)191:2<;127::AID-PATH614>3.0.CO;2-E
  22. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene. 1995; 10(8): 1545-1552.7731709
  23. Wang WY, Chien YC, Jan JS, Chueh CM, Lin JC. Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin Cancer Res. 2002; 8(8): 2586-2590.12171888
Language: English
Page range: 61 - 68
Published on: Aug 28, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2019 LD Thuan, ND Kha, NT Minh, LHA Thuy, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.